Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay

J Virol Methods. 2020 Oct:284:113925. doi: 10.1016/j.jviromet.2020.113925. Epub 2020 Jul 10.

Abstract

The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a range of SARS-CoV-2 loads and across established human coronaviruses.

Keywords: COBAS 6800; COVID-19; Diagnostics; GeneXpert; NAT; PCR; Respiratory infection; SARS-CoV-2; Viruses.

MeSH terms

  • Betacoronavirus / genetics
  • Betacoronavirus / isolation & purification*
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques / instrumentation
  • Clinical Laboratory Techniques / methods*
  • Clinical Laboratory Techniques / standards
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / virology*
  • Diagnostic Tests, Routine
  • Humans
  • Nasopharynx / virology
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / virology*
  • Polymerase Chain Reaction / instrumentation
  • Polymerase Chain Reaction / methods
  • Reproducibility of Results
  • SARS-CoV-2
  • Sensitivity and Specificity